IL135922A0 - Anaesthetic formulation - Google Patents

Anaesthetic formulation

Info

Publication number
IL135922A0
IL135922A0 IL13592298A IL13592298A IL135922A0 IL 135922 A0 IL135922 A0 IL 135922A0 IL 13592298 A IL13592298 A IL 13592298A IL 13592298 A IL13592298 A IL 13592298A IL 135922 A0 IL135922 A0 IL 135922A0
Authority
IL
Israel
Prior art keywords
saccharide
amount
additional non
anesthetic agent
anaesthetic formulation
Prior art date
Application number
IL13592298A
Other languages
English (en)
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9724506.2A external-priority patent/GB9724506D0/en
Priority claimed from GBGB9818109.2A external-priority patent/GB9818109D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of IL135922A0 publication Critical patent/IL135922A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
IL13592298A 1997-11-19 1998-11-19 Anaesthetic formulation IL135922A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9724506.2A GB9724506D0 (en) 1997-11-19 1997-11-19 Levobupivacaine and its use
GBGB9818109.2A GB9818109D0 (en) 1998-08-19 1998-08-19 Anaesthetic Formulation
PCT/GB1998/003479 WO1999025349A1 (en) 1997-11-19 1998-11-19 Anaesthetic formulation

Publications (1)

Publication Number Publication Date
IL135922A0 true IL135922A0 (en) 2001-05-20

Family

ID=26312628

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13592298A IL135922A0 (en) 1997-11-19 1998-11-19 Anaesthetic formulation

Country Status (18)

Country Link
US (1) US5932597A (xx)
EP (1) EP1032390B1 (xx)
JP (1) JP2001522888A (xx)
KR (1) KR100695588B1 (xx)
CN (1) CN1131033C (xx)
AT (1) ATE253913T1 (xx)
AU (1) AU740914B2 (xx)
BR (1) BR9814883A (xx)
CA (1) CA2308495C (xx)
DE (1) DE69819770T2 (xx)
DK (1) DK1032390T3 (xx)
ES (1) ES2209217T3 (xx)
HK (1) HK1026848A1 (xx)
HU (1) HU228143B1 (xx)
IL (1) IL135922A0 (xx)
NO (1) NO328684B1 (xx)
PT (1) PT1032390E (xx)
WO (1) WO1999025349A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824161D0 (en) * 1998-11-04 1998-12-30 Darwin Discovery Ltd Drug formulation
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
JP4865330B2 (ja) 2002-12-13 2012-02-01 デュレクト コーポレーション 経口ドラッグデリバリーシステム
AU2005287175B2 (en) 2004-09-17 2011-12-01 Durect Corporation Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
SG11201407323WA (en) * 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of local pain
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
EP3331508B1 (en) * 2015-07-13 2024-08-14 Neon Laboratories Ltd. Hyperbaric solution injection of levobupivacaine hydrochloride comprising levobupivacaine hydrochloride
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802564D0 (sv) * 1988-07-08 1988-07-08 Astra Ab New synergistic preparations and a new method of alleviation of pain
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
CN1074920C (zh) * 1993-10-13 2001-11-21 达尔文发现有限公司 止痛剂及其应用

Also Published As

Publication number Publication date
HK1026848A1 (en) 2000-12-29
DE69819770D1 (de) 2003-12-18
AU740914B2 (en) 2001-11-15
US5932597A (en) 1999-08-03
NO20002545L (no) 2000-05-18
HUP0004665A3 (en) 2004-05-28
WO1999025349A1 (en) 1999-05-27
HUP0004665A2 (hu) 2001-04-28
JP2001522888A (ja) 2001-11-20
KR20010032241A (ko) 2001-04-16
CA2308495C (en) 2009-01-06
EP1032390B1 (en) 2003-11-12
DK1032390T3 (da) 2004-03-15
ES2209217T3 (es) 2004-06-16
AU1168499A (en) 1999-06-07
NO328684B1 (no) 2010-04-26
CA2308495A1 (en) 1999-05-27
CN1279607A (zh) 2001-01-10
CN1131033C (zh) 2003-12-17
DE69819770T2 (de) 2004-09-23
HU228143B1 (en) 2012-12-28
ATE253913T1 (de) 2003-11-15
KR100695588B1 (ko) 2007-03-14
BR9814883A (pt) 2000-10-03
NO20002545D0 (no) 2000-05-18
PT1032390E (pt) 2004-04-30
EP1032390A1 (en) 2000-09-06

Similar Documents

Publication Publication Date Title
HK1026848A1 (en) Anaesthetic formulation
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
DE59204010D1 (de) Durch silberkolloid stabilisiertes wasserstoffperoxidenthaltendes mundhygienemittel.
EP0690722A4 (en) COMPOSITION AND METHOD FOR REDUCING THE TOXICITY OF BIOLOGICALLY ACTIVE FACTORS
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
MY130477A (en) Pharmaceutical compositions for the treatmen of mucositis, stomatitis and behcet,s syndrome
GR3030528T3 (en) Viscoelastic compositions of fluorinated organic compounds
AU2003298179A1 (en) Lens care composition and method
ES2721899T3 (es) Composiciones farmacéuticas que comprenden fentanilo para su administración intranasal
HUP0203773A2 (hu) Epinastintartalmú oldatok
JP2001522888A5 (xx)
ATE273033T1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
EA200001010A1 (ru) Применение дексмедетомидина для седативного воздействия в отделении интенсивной терапии
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
HUP0301506A2 (hu) Gyógyászati készítmények nedves hámfelületek fájdalmas, gyulladásos vagy fekélyes állapotai, így például nyálkahártyagyulladás, szájgyulladás és behcet-tünetcsoport kezelésére
PL322763A1 (en) Levobupivacaine and pplication thereof as anelgetic agent for pregnant women
GB2306885B (en) Supersaturated Pharmaceutical Compositions
DE60213464D1 (de) Amlopidinbezylat-tabletten mit verbesserter stabilität
ATE311891T1 (de) Cytidin-diphosphocholin gegen diabetische neuropathie
SE9003181D0 (sv) Use of heparin fraction
ES2159967T3 (es) Medicamento que contiene acido delta-aminolevulinico.
TH52586A (th) สารผสมเครื่องสำอาง
KR960701643A (ko) 겸상 적혈구 빈혈증, 말라리아 및 외인적으로 유발된 백혈구 감소증 치료를 위한 콜로이드성 이산화규소의 용도(Use of Collodidal Silicon Dioxide for Treating Sickle-Cell Anemia, Malaria and Exogenously Induced Leukopenias)
MX9603766A (es) Metodos de administracion de benzamidas n-substituidas o fenotiazinas.
BG94567A (en) Medicaments for the treatment of aids and method for its application

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
EXP Patent expired